Wegovy-maker Novo Nordisk sales soar 30% on strong demand for its weight-loss drug
August 10, 2023 at 02:07 AM EDT
The Danish company's diabetes and obesity division performed particularly well, bolstered by interest in its blockbuster injections Wegovy and Ozempic.
